Audubon Bioscience

Founded in 2016, Audubon Bioscience Co. (Audubon Bioscience or the company) is a biotechnology company offering biospecimen procurement services to pharma and biotech companies and government healthcare agencies. Customers utilize Audubon Bioscience’s services to gain access to human tissues and clinical history and data to further their research or other initiatives in a cost-effective manner. The company has a global clinical presence and is focused on helping customers further their research and development efforts for their diagnostic and treatment offerings. The company was founded by a former Oxford graduate and has grown quickly in the last few years.

Investors who purchase the first 100,000 Crowd Notes, and thereby fund the first $100,000, will receive Crowd Notes with a conversion provision based on a $7.5 million valuation cap instead of an $8 million valuation cap. That means, in connection with equity financing of at least $1 million, the company has the option to convert the Crowd Note into non-voting preferred shares (Conversion Shares) at a price based on the lower of (A) a 20% discount to the price per share paid for preferred shares by investors in the Qualified Equity Financing or (B) the price per share based on a $7.5 million valuation cap (instead of $8 million).

Generated ~$4.19 million in revenue in 2020, a 131% year-over-year increase
40+ customers across the public and private sector
Clinical sites in 12 countries around the globe
Notable customers include the U.S. National Cancer Institute and the U.S. Centers for Disease Control and Prevention (CDC)

• Intermediary Fees
• Equipment Purchases
• Future Wages
• General Working Capital

Dr. Rostyslav Semikov
CEO
Rostyslav Semikov founded Audubon Bioscience in 2016, after starting a postdoctoral fellowship at Louisiana State University Health Science Center. Before that, he worked in Ukraine as the Head of Development at East West Biopharma and as a business development manager at KM Techno. Semikov has also practiced medicine as a general practitioner before going into business and biomedical research. He earned his Masters of Science in Global Health Science from the University of Oxford in the United Kingdom and his M.D. from Zaporozhye State Medical University in Ukraine.

Maurice Cabirac
President
Maurice Cabirac joined the company in 2016 and focuses on business development consulting, company coordination, and special projects. Before Audubon Bioscience, he spent over two decades at ARC Mechanical Contractors in various project management and estimating manager roles. He also spent 15 years at Mechanical Construction Company in New Orleans. Cabirac graduated with his BA in Psychology from Southeastern Louisiana University.

Marie Cabirac
Finance
Marie Cabirac started at the company in 2016 and focuses on the financial efforts at the firm. Before joining the company, she spent her career at McDonough Marine Service, where she focused on bookkeeping, IT, special projects, and office management. She attended Southeastern Louisiana University, where she earned her BA in Marketing.

Discount Rate: 20%